by R. B. Cole (Monographs in Clinical Pharmacology, vol 5, Daniel L. Azarnoff, ed), 334 pp, with illus, $28.50, New York, Churchill Livingstone, 1981.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Drug Treatment of Respiratory Diseases is the latest in the growing series of books devoted to the pharmacology of the airways. Essentially aimed at the same audience, these books vary in size, number of contributing authors, and emphasis on basic pharmacology. This single-authored book was written by a British clinician for British and American clinicians.
The first chapter offers a clinical discussion on the pharmacokinetic and pharmacodynamic variables that, in general, are apt to influence the response to drugs. The following chapters deal with drugs affecting cough and sputum production, anti-microbials, bronchodilating drugs, corticosteroids, anticoagulants, and therapeutic measures applied in acute respiratory failure. There are good but sparse diagrams, a lot of summarizing tables, and pertinent selected references up to 1979.
Clear, systematic, and concise, the book is obviously written with literary and didactic talent. Without being ponderous or dogmatic, the author artfully presents the current consensus on a certain
Popa VT. Drug Treatment of Respiratory Disease. JAMA. 1982;247(18):2595-2596. doi:10.1001/jama.1982.03320430091045